124 related articles for article (PubMed ID: 7732895)
21. [Antagonists of platelet activating factor].
Tokumura A; Tsukatani H
Seikagaku; 1985 Dec; 57(12):1618-23. PubMed ID: 3009656
[No Abstract] [Full Text] [Related]
22. A simple, rapid and specific radioreceptor assay for platelet-activating factor.
Aoki Y; Nakamura M; Kodama H; Shimizu T
Adv Exp Med Biol; 1997; 407():459-64. PubMed ID: 9321990
[No Abstract] [Full Text] [Related]
23. Platelet-activating factor antagonists as therapeutic strategy in sepsis.
Dhainaut JF; Mira JP; Brunet F
Prog Clin Biol Res; 1994; 388():277-93. PubMed ID: 7831364
[No Abstract] [Full Text] [Related]
24. Discovery and evaluation of a series of 3-acylindole imidazopyridine platelet-activating factor antagonists.
Curtin ML; Davidsen SK; Heyman HR; Garland RB; Sheppard GS; Florjancic AS; Xu L; Carrera GM; Steinman DH; Trautmann JA; Albert DH; Magoc TJ; Tapang P; Rhein DA; Conway RG; Luo G; Denissen JF; Marsh KC; Morgan DW; Summers JB
J Med Chem; 1998 Jan; 41(1):74-95. PubMed ID: 9438024
[TBL] [Abstract][Full Text] [Related]
25. Formation of spherical micelles by the novel platelet activating factor receptor antagonist, E5880.
Nomura T; Asai Y; Murahashi N; Iwamoto K
Chem Pharm Bull (Tokyo); 2000 Jul; 48(7):947-50. PubMed ID: 10923821
[TBL] [Abstract][Full Text] [Related]
26. The platelet activating factor receptor antagonist, RP 59227, blocks platelet activating factor receptors mediating liberation of reactive oxygen species in guinea pig macrophages and human polymorphonuclear leukocytes.
Floch A; Tahraoui L; Sedivy P; Cavero I
J Pharmacol Exp Ther; 1991 Aug; 258(2):567-75. PubMed ID: 1650834
[TBL] [Abstract][Full Text] [Related]
27. Formation of spherical micelles composed of the novel platelet activating factor receptor antagonist, E5880.
Asai Y
Pharm Dev Technol; 2005; 10(1):11-6. PubMed ID: 15776809
[TBL] [Abstract][Full Text] [Related]
28. 4-substituted 2-alkoxytetrahydrofurans as potent and long-lasting PAF antagonists.
Carceller E; Merlos M; Giral M; Bartrolí J; García-Rafanell J; Forn J
J Med Chem; 1992 Feb; 35(4):676-83. PubMed ID: 1542094
[TBL] [Abstract][Full Text] [Related]
29. PAF, rather than histamine, participates in mouse anaphylactic hypotension.
Shibamoto T; Liu W; Cui S; Zhang W; Takano H; Kurata Y
Pharmacology; 2008; 82(2):114-20. PubMed ID: 18583921
[TBL] [Abstract][Full Text] [Related]
30. Beneficial effects of a novel platelet-activating factor receptor antagonist, ST 899, on endotoxin-induced shock in mice.
Ruggiero V; Chiapparino C; Manganello S; Pacello L; Foresta P; Martelli EA
Shock; 1994 Oct; 2(4):275-80. PubMed ID: 7757521
[TBL] [Abstract][Full Text] [Related]
31. Isolation and characterization of platelet-activating factor receptor binding antagonists from Biota orientalis.
Yang HO; Suh DY; Han BH
Planta Med; 1995 Feb; 61(1):37-40. PubMed ID: 7700989
[TBL] [Abstract][Full Text] [Related]
32. Recent development of platelet-activating factor antagonists.
Shen TY; Hussaini I; Hwang SB; Chang MN
Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():359-62. PubMed ID: 2546389
[No Abstract] [Full Text] [Related]
33. PAF-agonistic and -antagonistic behaviour of new synthetic ether phospholipids. I. Studies on blood platelets in vitro.
Ostermann G; Hofmann B; Kertscher HP; Till U
J Lipid Mediat; 1990; 2(1):21-31. PubMed ID: 1966804
[TBL] [Abstract][Full Text] [Related]
34. [Platelet-activating factor (PAF) antagonists].
Terasawa M
Tanpakushitsu Kakusan Koso; 1991 Feb; 36(3):379-87. PubMed ID: 1850862
[No Abstract] [Full Text] [Related]
35. Lexipafant (BB-882), a potent PAF antagonist in acute pancreatitis.
Curtis LD
Adv Exp Med Biol; 1996; 416():361-3. PubMed ID: 9131174
[No Abstract] [Full Text] [Related]
36. Platelet activating factor (PAF) antagonists: development of a highly potent PAF antagonist, TCV-309.
Takatani M; Maezaki N; Imura Y; Terashita Z; Nishikawa K; Tsushima S
Adv Prostaglandin Thromboxane Leukot Res; 1991; 21B():943-6. PubMed ID: 1825438
[No Abstract] [Full Text] [Related]
37. Kadsurenone and other related lignans as antagonists of platelet-activating factor receptor.
Shen TY; Hussaini IM
Methods Enzymol; 1990; 187():446-54. PubMed ID: 2172742
[No Abstract] [Full Text] [Related]
38. Antiinflammatory activity of the platelet-activating factor receptor antagonist A-85783.
Travers J; Pei Y; Morin SM; Hood AF
Arch Dermatol Res; 1998 Oct; 290(10):569-73. PubMed ID: 9836508
[TBL] [Abstract][Full Text] [Related]
39. Biochemical and pharmacological activities of SR 27417, a highly potent, long-acting platelet-activating factor receptor antagonist.
Herbert JM; Bernat A; Valette G; Gigo V; Lale A; LaPlace MC; Lespy L; Savi P; Maffrand JP; Le Fur G
J Pharmacol Exp Ther; 1991 Oct; 259(1):44-51. PubMed ID: 1656029
[TBL] [Abstract][Full Text] [Related]
40. Platelet-activating factor receptor.
Izumi T; Takano T; Bito H; Nakamura M; Mutoh H; Honda Z; Shinizu T
J Lipid Mediat Cell Signal; 1995 Oct; 12(2-3):429-42. PubMed ID: 8777584
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
